Table 2:

Representative spectroscopy points and prognostic performance

VariableValueOverall PatientsPPatients Treated with ChemoradiotherapyConservative-Support TreatmentP
No.Hazard Ratio (95% CI)No.Hazard Ratio (95% CI)PNo.Hazard Ratio (95% CI)
STEa
    NI0.98<0.10241330.568 (0.391–0.826).003720.424 (0.231–0.778).006380.575 (0.323–1.026)NS
>0.1024471.000181.000201.000
    NI3.67<0.0473711.992 (1.421–2.792)<.001292.080 (1.238–3.495).006282.038 (1.122–3.699).018
>0.04731091.000611.000301.000
STEb
    I3.67/I0.98<0.5510761.866 (1.329–2.621)<.001342.673 (1.582–4.517)<.001291.960 (1.071–3.586).029
>0.55101041.000561.000291.000
LTEa
    NI0.98<0.02671030.426 (0.304–0.597)<.001570.417 (0.249–0.698).001380.472 (0.259–0.860).014
>0.0267791.000321.000211.000
    NI1.25<0.0098590.400 (0.272–0.590)<.001390.434 (0.252–0.748).003100.412 (0.187–0.905).027
>0.00981231.000501.000491.000
  • a Intensity values of points normalized to unit-length: NIx.xx

  • b Ratio between intensity signals of points: Ix.xx/Ix.xx.